The incidence of coronary heart disease (CAD) has soared over the years, and coronary
intervention has become an increasingly important therapeutic approach. The past decade …

Background Drug-coated balloons (DCB), alone or in combination with drug-eluting stents
(DES), may be used to treat diffuse coronary lesions. We aimed to explore the efficacy and …

Drug-coated balloons have emerged as a promising therapeutic option in the treatment of
cardiovascular disease. This review article provides an overview of the concept of drug …

Backgrounds. Many clinical trials have demonstrated the value of drug‐coated balloons
(DCB) for in‐stent restenosis. However, their role in de novo lesions is not well documented …

Background Data on drug-coated balloon (DCB) treatment in the context of diabetes mellitus
(DM) and multivessel coronary artery disease (CAD) are limited. We aimed to investigate the …

Long-term clinical outcomes of drug-coated balloon for the m... : Coronary Artery Disease
Long-term clinical outcomes of drug-coated balloon for the management of chronic total …

Background With advancements in chronic total coronary occlusion (CTO) recanalization
techniques and concepts, the success rate of recanalization has been steadily increasing …

Background: Percutaneous coronary intervention (PCI) with a drug-eluting stent (DES) for
chronic total coronary occlusions (CTOs) improves clinical symptoms and quality of life …

Background Concerns regarding restenosis after treatment with drug-coated balloons (DCB)
remain. We aimed to identify the incidence of target lesion revascularization (TLR) and …

Background and Objectives: Percutaneous coronary intervention (PCI) of chronic total
occlusion (CTO) is often associated with longer total stent length. Our aim was to evaluate …